OUR LAB

Who we are & what we do

Hello! We are immunomodulationlab at IdiPAZ

Immunomodulation lab at IdiPAZ, lead by CArlos del Fresno Sánchez PhD, is interested in the understanding and harnessing of the innate immune system to improve protective responses against pathological challenges, such as infections or tumors.

Official website of the Immunomodulation Lab at Hospital La Paz Institute for Health Research (IdiPAZ), headed by Carlos del Fresno Sánchez PhD.

We are part of the Innate Immunity Research Group.

The research that we performed at the Immunomodulation lab at the Hospital la Paz Institute for Health Research (IdiPAZ) is focused on the detection and modulation of innate immune responses in the context of cancer and infection.

Our current research is structured in 4 research lines: Trained Immunity against cancer, immunological responses to clinical therapies, cancer biomarkers and antitumor vaccines.

Among our publications

01.

Quality

One of the favorite words of the Immunomodulation lab is “excellence.”

02.

Integrity

Data drive our conclusions. Control conditions first. Then, experimental data.

03.

Innovations

Crazy ideas? As long as they are supported on a biological rationale, why not?

04.

Fun

It all is much better if you enjoy what you do. We try to make science fun.

PUBLICATIONS

Our last publications

Do you want to know more about our publications? Discuss our results? Suggest new experiments?

Contact us

Research Lines

How we can be useful for you

Check Out Our Research Lines!

Our current research is structured in 4 research lines: Trained Immunity against cancer, immunological responses to clinical therapies, cancer biomarkers and antitumor vaccines.

Immunomodulation means to shape immunity towards our interests, and we take it in a broad way. What do we do? Check it out!!

Trained Immunity against cancer

In the last three years we have been involved in a number of works related to trained immunity (Mata-Martínez, P., et al., Front. Immunol., 2022).

Antitumor vaccines

We are interested in cancer vaccines of potential clinical application. In this sense, we are studying an antitumor vaccine based on a tumor-derived antigen named Ca10.

Cancer biomarkers

Therefore, in addition to suggest the potential application of the above-mentioned vaccine, plasma Ca10 levels could represent a new prognosis marker.

Immunological responses to clinical therapies

Based on our deep experience in the cellular biology of immune responses (del Fresno, C., et al., Science, 2018)

CONTACT

Contact us!

OUR LOCATION

C. de Pedro Rico, 6,

28029 Madrid

CALL US

+34-7277000-442943

Let's start a project together!

Interested in the modulation of innate immune cells? Do you want to know more from us? Do not hesitate to contact us.

 

Send Message